1. Food and Drug Administration. FDA grants traditional approval to tarlatamab-dlle for extensive-stage small-cell lung cancer. FDA. November 19, 2025. Accessed November 19, 2025.
The patient count in an outbreak of infant botulism linked to ByHeart formula is continuing to increase, and federal ...
Public News Service on MSN
IN consumers have options for food and product recalls
The frequency of food recalls is setting off alarms about the safety of the products we eat. Recent food recalls in Indiana ...
Varanasi: Joint team of food safety and drug administration, police and ANTF recovered a stock of 93,750 bottles of ...
The health secretary and his FDA chief, Marty Makary, can’t agree on how to proceed with vaccine safety studies.
The ANDROMEDA trial showed improved MOD-PFS and OS with daratumumab and hyaluronidase plus VCd compared to VCd alone in light ...
NDA based on data from global ARROS-1 Phase 1/2 clinical trial FDA assigns PDUFA target action date of September 18, 2026 CAMBRIDGE, Mass., Nov. 19, 2025 ...
The FDA said it received multiple reports that the baby formula is still being found on store shelves in multiple states.
As Saudi Arabia’s ambitious Vision 2030 program transforms the nation into a nexus of cultural riches and scientific ...
The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
Agios Pharmaceuticals, Inc. drops after mixed Phase 3 mitapivat results in Sickle Cell Disease. Click here to find out why ...
In recent weeks, at least 23 infants in the U.S. have been infected with botulism in an outbreak linked to ByHeart powdered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback